FEISTY Junior will perform the same trial, except in children aged 3 months to 18 years. There are currently no published studies comparing fibrinogen concentrate and cryoprecipitate in the paediatric population. While the FEISTY study is focused on the best way to treat the condition, Brian is optimistic that a sub-study into why some people develop this counterintuitive clotting problem immediately after injury will be done down the track.
“People have this condition and we need to understand why and who’s at risk, so we can pick it up early and manage this clotting problem before it becomes critical,” he says. But for now, by focusing on a clearly defined clotting disorder in trauma cases, the study aims to generate evidence that could reshape care worldwide.
“People have this condition and we need to understand why and
who’s at risk, so we can pick it up early and manage this clotting problem before it becomes critical.”
Professor Brian Burns
7
Made with FlippingBook - professional solution for displaying marketing and sales documents online